These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33722668)

  • 21. Tpl2 kinase signal transduction in inflammation and cancer.
    Vougioukalaki M; Kanellis DC; Gkouskou K; Eliopoulos AG
    Cancer Lett; 2011 May; 304(2):80-9. PubMed ID: 21377269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function.
    Sun F; Qu Z; Xiao Y; Zhou J; Burns TF; Stabile LP; Siegfried JM; Xiao G
    Oncogene; 2016 May; 35(18):2299-310. PubMed ID: 26300007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
    Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
    Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A serine/threonine kinase, Cot/Tpl2, modulates bacterial DNA-induced IL-12 production and Th cell differentiation.
    Sugimoto K; Ohata M; Miyoshi J; Ishizaki H; Tsuboi N; Masuda A; Yoshikai Y; Takamoto M; Sugane K; Matsuo S; Shimada Y; Matsuguchi T
    J Clin Invest; 2004 Sep; 114(6):857-66. PubMed ID: 15372110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancer.
    Lee HW; Choi HY; Joo KM; Nam DH
    Int J Mol Sci; 2015 Feb; 16(3):4471-91. PubMed ID: 25723737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza-induced Tpl2 expression within alveolar epithelial cells is dispensable for host viral control and anti-viral immunity.
    Wyatt KD; Sarr D; Sakamoto K; Watford WT
    PLoS One; 2022; 17(1):e0262832. PubMed ID: 35051238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis.
    Koliaraki V; Roulis M; Kollias G
    J Clin Invest; 2012 Nov; 122(11):4231-42. PubMed ID: 23064365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor progression locus-2 is a critical regulator of pancreatic and lung inflammation during acute pancreatitis.
    Van Acker GJ; Perides G; Weiss ER; Das S; Tsichlis PN; Steer ML
    J Biol Chem; 2007 Jul; 282(30):22140-9. PubMed ID: 17537724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial Tpl2 regulates vascular barrier function via JNK-mediated degradation of claudin-5 promoting neuroinflammation or tumor metastasis.
    Nanou A; Bourbouli M; Vetrano S; Schaeper U; Ley S; Kollias G
    Cell Rep; 2021 May; 35(8):109168. PubMed ID: 34038728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor progression locus 2 mediates signal-induced increases in cytoplasmic calcium and cell migration.
    Hatziapostolou M; Koukos G; Polytarchou C; Kottakis F; Serebrennikova O; Kuliopulos A; Tsichlis PN
    Sci Signal; 2011 Aug; 4(187):ra55. PubMed ID: 21868363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor progression locus 2-dependent oxidative burst drives phosphorylation of extracellular signal-regulated kinase during TLR3 and 9 signaling.
    Kuriakose T; Rada B; Watford WT
    J Biol Chem; 2014 Dec; 289(52):36089-100. PubMed ID: 25378393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MAP3K8 (TPL2/COT) affects obesity-induced adipose tissue inflammation without systemic effects in humans and in mice.
    Ballak DB; van Essen P; van Diepen JA; Jansen H; Hijmans A; Matsuguchi T; Sparrer H; Tack CJ; Netea MG; Joosten LA; Stienstra R
    PLoS One; 2014; 9(2):e89615. PubMed ID: 24586913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor progression locus 2 differentially regulates IFNγ and IL-17 production by effector CD4+ T cells in a T cell transfer model of colitis.
    Acuff NV; Li X; Kirkland R; Nagy T; Watford WT
    PLoS One; 2015; 10(3):e0119885. PubMed ID: 25781948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TPL2 kinase regulates the inflammatory milieu of the myeloma niche.
    Hope C; Ollar SJ; Heninger E; Hebron E; Jensen JL; Kim J; Maroulakou I; Miyamoto S; Leith C; Yang DT; Callander N; Hematti P; Chesi M; Bergsagel PL; Asimakopoulos F
    Blood; 2014 May; 123(21):3305-15. PubMed ID: 24723682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal myofibroblast-specific Tpl2-Cox-2-PGE2 pathway links innate sensing to epithelial homeostasis.
    Roulis M; Nikolaou C; Kotsaki E; Kaffe E; Karagianni N; Koliaraki V; Salpea K; Ragoussis J; Aidinis V; Martini E; Becker C; Herschman HR; Vetrano S; Danese S; Kollias G
    Proc Natl Acad Sci U S A; 2014 Oct; 111(43):E4658-67. PubMed ID: 25316791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cot/tpl2 (MAP3K8) mediates myeloperoxidase activity and hypernociception following peripheral inflammation.
    Soria-Castro I; Krzyzanowska A; Pelaéz ML; Regadera J; Ferrer G; Montoliu L; Rodríguez-Ramos R; Fernández M; Alemany S
    J Biol Chem; 2010 Oct; 285(44):33805-15. PubMed ID: 20736176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serine/threonine kinase, Cot/Tpl2, regulates renal cell apoptosis in ischaemia/reperfusion injury.
    Yaomura T; Tsuboi N; Urahama Y; Hobo A; Sugimoto K; Miyoshi J; Matsuguchi T; Reiji K; Matsuo S; Yuzawa Y
    Nephrology (Carlton); 2008 Oct; 13(5):397-404. PubMed ID: 18518937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TPL2 meets p38MAPK: emergence of a novel positive feedback loop in inflammation.
    Menon MB; Gaestel M
    Biochem J; 2016 Oct; 473(19):2995-9. PubMed ID: 27679858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations.
    Dodhiawala PB; Khurana N; Zhang D; Cheng Y; Li L; Wei Q; Seehra K; Jiang H; Grierson PM; Wang-Gillam A; Lim KH
    J Clin Invest; 2020 Sep; 130(9):4771-4790. PubMed ID: 32573499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implication of the Tpl2 kinase in inflammatory changes and insulin resistance induced by the interaction between adipocytes and macrophages.
    Ceppo F; Berthou F; Jager J; Dumas K; Cormont M; Tanti JF
    Endocrinology; 2014 Mar; 155(3):951-64. PubMed ID: 24424060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.